📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. (2021)

First Author: Vasey CE

Attributed to: Radiotherapy activated materials for enhanced cancer treatments funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13020208

PubMed Identifier: 33546301

Publication URI: http://europepmc.org/abstract/MED/33546301

Type: Journal Article/Review

Volume: 13

Parent Publication: Pharmaceutics

Issue: 2

ISSN: 1999-4923